158 related articles for article (PubMed ID: 17594630)
1. [O-Twist Marker for marking breast cancer under neoadjuvant chemotherapy--first results].
Viehweg P; Fabel K; Petzold A; Friedrich K; Laniado M
Rofo; 2007 Oct; 179(10):1055-60. PubMed ID: 17594630
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of the dislocation and long-term sonographic detectability of a hydrogel-based breast biopsy site marker.
Sakamoto N; Fukuma E; Tsunoda Y; Teraoka K; Koshida Y
Breast Cancer; 2018 Sep; 25(5):575-582. PubMed ID: 29572658
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of tissue marker clips in patients undergoing neoadjuvant chemotherapy for breast cancer.
Dash N; Chafin SH; Johnson RR; Contractor FM
AJR Am J Roentgenol; 1999 Oct; 173(4):911-7. PubMed ID: 10511147
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Marker Clip System in Sonographically Guided Core Needle Biopsy for Breast Cancer Localization Before and After Neoadjuvant Chemotherapy.
Schulz-Wendtland R; Dankerl P; Bani MR; Fasching PA; Heusinger K; Lux MP; Jud SM; Rauh C; Bayer CM; Schrauder MG; Beckmann MW; Uder M; Brehm B; Loehberg CR
Geburtshilfe Frauenheilkd; 2017 Feb; 77(2):169-175. PubMed ID: 28331239
[No Abstract] [Full Text] [Related]
5. Defining radiologic complete response using a correlation of presurgical ultrasound and mammographic localization findings with pathological complete response following neoadjuvant chemotherapy in breast cancer.
Makanjuola DI; Alkushi A; Al Anazi K
Eur J Radiol; 2020 Sep; 130():109146. PubMed ID: 32673929
[TBL] [Abstract][Full Text] [Related]
6. Clinical and radiologic assessments to predict breast cancer pathologic complete response to neoadjuvant chemotherapy.
Schott AF; Roubidoux MA; Helvie MA; Hayes DF; Kleer CG; Newman LA; Pierce LJ; Griffith KA; Murray S; Hunt KA; Paramagul C; Baker LH
Breast Cancer Res Treat; 2005 Aug; 92(3):231-8. PubMed ID: 16155794
[TBL] [Abstract][Full Text] [Related]
7. Outcome and Cost Effectiveness of Ultrasonographically Guided Surgical Clip Placement for Tumor Localization in Patients undergoing Neo-adjuvant Chemotherapy for Breast Cancer.
Masroor I; Zeeshan S; Afzal S; Sufian SN; Ali M; Khan S; Ahmad K
Asian Pac J Cancer Prev; 2015; 16(18):8339-43. PubMed ID: 26745082
[TBL] [Abstract][Full Text] [Related]
8. [Do tissue marker clips after sonographically or stereotactically guided breast biopsy improve follow-up of small breast lesions and localisation of breast cancer after chemotherapy?].
Schulz-Wendtland R; Heywang-Köbrunner SH; Aichinger U; Krämer S; Wenkel E; Bautz W
Rofo; 2002 May; 174(5):620-4. PubMed ID: 11997863
[TBL] [Abstract][Full Text] [Related]
9. Imaging breast cancer.
Bartella L; Smith CS; Dershaw DD; Liberman L
Radiol Clin North Am; 2007 Jan; 45(1):45-67. PubMed ID: 17157623
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
Peintinger F; Kuerer HM; Anderson K; Boughey JC; Meric-Bernstam F; Singletary SE; Hunt KK; Whitman GJ; Stephens T; Buzdar AU; Green MC; Symmans WF
Ann Surg Oncol; 2006 Nov; 13(11):1443-9. PubMed ID: 17028770
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic accuracy of mammography, ultrasonography and magnetic resonance imaging in the detection of intraductal spread of breast cancer following neoadjuvant chemotherapy.
Kubota K; Ogawa Y; Nishioka A; Kariya S; Itoh S; Murata Y; Hamada N; Maeda H; Tanaka Y
Oncol Rep; 2007 Apr; 17(4):915-8. PubMed ID: 17342336
[TBL] [Abstract][Full Text] [Related]
12. Relative value of physical examination, mammography, and breast sonography in evaluating the size of the primary tumor and regional lymph node metastases in women receiving neoadjuvant chemotherapy for locally advanced breast carcinoma.
Herrada J; Iyer RB; Atkinson EN; Sneige N; Buzdar AU; Hortobagyi GN
Clin Cancer Res; 1997 Sep; 3(9):1565-9. PubMed ID: 9815844
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Guided Diffuse Optical Tomography for Predicting and Monitoring Neoadjuvant Chemotherapy of Breast Cancers: Recent Progress.
Xu C; Vavadi H; Merkulov A; Li H; Erfanzadeh M; Mostafa A; Gong Y; Salehi H; Tannenbaum S; Zhu Q
Ultrason Imaging; 2016 Jan; 38(1):5-18. PubMed ID: 25887527
[TBL] [Abstract][Full Text] [Related]
14. Using Flow Characteristics in Three-Dimensional Power Doppler Ultrasound Imaging to Predict Complete Responses in Patients Undergoing Neoadjuvant Chemotherapy.
Shia WC; Huang YL; Wu HK; Chen DR
J Ultrasound Med; 2017 May; 36(5):887-900. PubMed ID: 28109009
[TBL] [Abstract][Full Text] [Related]
15. Role of sentinel lymphadenectomy combined with intraoperative ultrasound in the assessment of locally advanced breast cancer after neoadjuvant chemotherapy.
Yu JC; Hsu GC; Hsieh CB; Yu CP; Chao TY
Ann Surg Oncol; 2007 Jan; 14(1):174-80. PubMed ID: 17066228
[TBL] [Abstract][Full Text] [Related]
16. Sonographically guided metalic clip placement for tumour localization in early breast cancer patients undergoing neoadjuvant chemotherapy.
Shahzad R; Masood M; Shahid A; Mirza ZR; Cheema FE; Fatima I
J Pak Med Assoc; 2019 Oct; 69(10):1501-1504. PubMed ID: 31622305
[TBL] [Abstract][Full Text] [Related]
17. Does MRI predict pathologic tumor response in women with breast cancer undergoing preoperative chemotherapy?
Segara D; Krop IE; Garber JE; Winer E; Harris L; Bellon JR; Birdwell R; Lester S; Lipsitz S; Iglehart JD; Golshan M
J Surg Oncol; 2007 Nov; 96(6):474-80. PubMed ID: 17640031
[TBL] [Abstract][Full Text] [Related]
18. [Preoperative wire localisation of breast lesions by tissue harmonic imaging (THI) sonography].
Jung EM; Clevert DA; Lutz R; Kett H; Rupp N
Rofo; 2002 Sep; 174(9):1121-5. PubMed ID: 12221570
[TBL] [Abstract][Full Text] [Related]
19. Accuracy of clinical examination, digital mammogram, ultrasound, and MRI in determining postneoadjuvant pathologic tumor response in operable breast cancer patients.
Croshaw R; Shapiro-Wright H; Svensson E; Erb K; Julian T
Ann Surg Oncol; 2011 Oct; 18(11):3160-3. PubMed ID: 21947594
[TBL] [Abstract][Full Text] [Related]
20. Magnetic Resonance Imaging after Completion of Neoadjuvant Chemotherapy Can Accurately Discriminate between No Residual Carcinoma and Residual Ductal Carcinoma In Situ in Patients with Triple-Negative Breast Cancer.
Park S; Yoon JH; Sohn J; Park HS; Moon HJ; Kim MJ; Kim EK; Kim SI; Park BW
PLoS One; 2016; 11(2):e0149347. PubMed ID: 26866475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
